What are the opening hours?

Monday 8am - 10pm Tuesday 8am - 10pm Wednesday 8am - 10pm Thursday 8am - 10pm Friday 8am - 10pm Saturday 10am - 3pm Sunday 12pm - 10pm

Collier Legal, LLC

Home
United States
Medina, OH
Collier Legal, LLC

Call Directions Website Contact the practice

Intellectual property law firm with locations in Ohio, New York and Missouri.

10/25/2026

Biotechnology innovation can take years of research, experimentation, and development. Protecting those discoveries requires patent counsel that understands the underlying science and the commercial goals behind the invention.

Collier Legal works with life sciences innovators on patent protection for complex biotechnology inventions.

Learn more about our biotechnology patent services:
https://collierlegaloh.com/biotechnology-patent-attorneys/

Our biotechnology patent attorneys utilize their advanced degrees to help clients capture and protect their biological innovations.

09/26/2026

Do you need testing data before filing a patent?

Not always. But testing can be particularly important for biotechnology, pharmaceutical, and other inventions where the relationship between structure and function may be difficult to predict.

Testing data can help establish utility, support broader genus claims, support a claimed therapeutic or functional result, and demonstrate unexpected or superior results over the prior art.

The key is having the right data to support the invention and the scope of protection being sought.

Read more about the role of testing data in patent applications:

Learn how testing data supports patent applications, including utility, working examples, genus claims, claimed and unexpected results.

07/25/2026

Software patent eligibility can be one of the most challenging issues for companies developing SaaS platforms, AI systems, and other computer-implemented technologies.

In our latest article, we examine key considerations under 35 U.S.C. § 101, including the Alice/Mayo framework, abstract ideas, tailored software, innovative coding, technical improvements, and the importance of claiming the technical solution rather than simply the desired result.

Read the full article:
https://collierlegaloh.com/key-considerations-for-software-patent-eligibility/

Learn key considerations for software patent eligibility under 35 U.S.C. § 101, including the Alice/Mayo framework.

06/26/2026

Many biotechnology and pharmaceutical patent applications receive a Restriction Requirement from the USPTO. While this can be frustrating, it is often a normal part of patent prosecution rather than an indication that the application was improperly drafted.

In this article, I discuss why restriction requirements are so common in the life sciences, how they affect patent strategy, and what applicants should expect during prosecution.

https://collierlegaloh.com/why-life-science-patents-usually-face-a-restriction-requirement/

Life science patent applications often receive a restriction requirement because they disclose multiple inventions, species, or claim groups.

06/09/2026

Who owns intellectual property created through university research?

Many researchers assume they own the inventions they help create. In reality, ownership often depends on university policies, employment agreements, funding sources, and federal laws such as the Bayh Dole Act.

Our latest article explains how universities, faculty members, students, and research sponsors may each have rights in university developed intellectual property.

Read more:
https://collierlegaloh.com/who-owns-university-research-ip/

Discover how university research IP ownership works, including inventorship, assignment agreements, licensing, and university spinouts.

05/25/2026

Signing a trademark license is only the beginning. If it is not properly monitored, it can create “naked license” risk that may weaken trademark rights.

This article explains what can go wrong and why ongoing oversight matters.

A signed trademark license is not enough. Learn how unmonitored trademark use can create naked license risk and threaten brand rights.

05/08/2026

The USPTO issued a significant SMED update on April 30, 2026, revising guidance concerning Rule 132 Subject Matter Eligibility Declarations used to address § 101 patent eligibility rejections.

The update is especially relevant for:
• Software patents
• Artificial intelligence inventions
• Fintech applications
• Medical diagnostics
• Other technologies facing abstract idea rejections

The revised guidance suggests the USPTO is increasingly receptive to factual evidence demonstrating concrete technological improvements and practical applications.

Read our analysis here:
https://collierlegaloh.com/uspto-smed-update-april-2026/

The USPTO SMED update issued April 30, 2026 revises guidance for Rule 132 subject matter eligibility declarations.

04/12/2026

Who owns an employee’s invention?

It is not always the employer. Without a proper invention assignment agreement, employees may retain ownership, and companies may be left with only limited rights.

This article explains how patent law, contracts, and employment roles determine ownership.

Who owns employee inventions? Learn how invention assignment agreements, shop rights, and patent law determine ownership.

Address

5042 Grande Boulevard
Medina, OH
44256

Opening Hours

Monday	8am - 10pm
Tuesday	8am - 10pm
Wednesday	8am - 10pm
Thursday	8am - 10pm
Friday	8am - 10pm
Saturday	10am - 3pm
Sunday	12pm - 10pm

Telephone

+16147953216

Website

https://www.collierlegaloh.com/

Alerts

Be the first to know and let us send you an email when Collier Legal, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.